Non-invasive prenatal testing does NOT study hereditary diseases. This testing only studies chromosomal alterations. If there is a suspicion of a pregnancy affected by a hereditary (monogenic) disease, invasive prenatal testing on an amniotic fluid sample (amniocentesis) is indicated.
When transferring an embryo analysed via PGT-M, the recommendation is the same, but the probability of an altered result is considerably lower.